ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

ATXI Avenue Therapeutics Inc

6.43
-2.35 (-26.72%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Avenue Therapeutics Inc ATXI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-2.35 -26.72% 6.43 08:26:06
개장가 저가 고가 종가 전일 종가
7.58 5.78 8.99 6.20 8.775
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/04/202420:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
25/03/202421:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
19/03/202405:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
15/03/202421:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
11/03/202421:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
09/03/202406:31EDGAR2Form PRE 14C - Other preliminary information statements
09/03/202406:15EDGAR2Form 8-K - Current report
22/02/202422:30GLOBEAvenue Therapeutics Announces Publication in Drug..
02/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
29/01/202422:00EDGAR2Form DEF 14C - Other definitive information statements
25/01/202406:11EDGAR2Form S-3 - Registration statement under Securities Act of..
18/01/202407:05EDGAR2Form PRE 14C - Other preliminary information statements
12/01/202420:01EDGAR2Form 8-K - Current report
11/01/202422:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
09/01/202407:28EDGAR2Form 8-K - Current report
05/01/202423:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
04/01/202422:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
02/01/202422:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
14/12/202306:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/12/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202322:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
29/11/202306:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/11/202306:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/11/202303:19EDGAR2Form 8-K - Current report
14/11/202306:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202306:10EDGAR2Form 8-K - Current report
14/11/202306:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
03/11/202305:10EDGAR2Form 8-K - Current report
03/11/202304:00GLOBEAvenue Therapeutics Announces Closing of $5.0 Million Public..
02/11/202322:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
31/10/202322:15GLOBEAvenue Therapeutics Announces Pricing of $5.0 Million Public..
06/10/202306:05EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
30/09/202306:23EDGAR2Form S-1/A - General form for registration of securities..
29/09/202305:25EDGAR2Form 8-K - Current report
28/09/202305:03EDGAR2Form 8-K - Current report
19/09/202306:18EDGAR2Form S-1 - General form for registration of securities under..
09/09/202305:15EDGAR2Form 8-K - Current report
05/09/202321:30GLOBEAvenue Therapeutics to Present at H.C. Wainwright 25th..
15/08/202305:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
12/08/202305:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:20EDGAR2Form 8-K - Current report
11/08/202305:15GLOBEAvenue Therapeutics Reports Second Quarter 2023 Financial..
01/08/202321:30GLOBEAvenue Therapeutics Announces High Potency and Full Efficacy..
27/07/202321:30GLOBEAvenue Therapeutics Announces First Patient Dosed in Phase..
25/07/202321:30GLOBEAvenue Therapeutics Announces Agreement with the FDA on the..
22/07/202305:37EDGAR2Form 8-K - Current report
06/07/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202305:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202305:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/07/202302:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock